Recent Finacing
Recent Raise
Oleolive is a preclinical biotechnology company developing OL-003, a blood–brain barrier–penetrant dual PPAR agonist for Alzheimer's and other CNS indications, and producing Oligen olive-derived oleocanthal/oleacein.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Oleolive.
